التفاصيل البيبلوغرافية
| العنوان: |
Reducing Delays in Breast Cancer Care Using an Innovative Digital Health Platform. |
| المؤلفون: |
HOLMES, DENNIS R., EVANS, STEVEN D., FISHER, WARREN, WHEELER, DARREN, PULICHARAM, RIYA |
| المصدر: |
American Journal of Accountable Care; Jun2024, Vol. 12 Issue 2, p23-29, 7p |
| مصطلحات موضوعية: |
DIGITAL health, BREAST cancer, CANCER treatment, DIGITAL technology, CORE needle biopsy, HEALTH boards |
| مصطلحات جغرافية: |
NEVADA |
| مستخلص: |
Objectives: Among women with early-stage breast cancer, prolonged time from core needle biopsy to initiation of treatment is associated with a lower rate of overall survival. The primary goal of this study was to reduce historical time to treatment (TTT) by greater than 50%. A secondary goal was to reduce TTT to fewer than 30 days to minimize the adverse impact of a delay on survival. Study Design: We conducted an institutional review board-approved quality improvement initiative among patients with Medicare Advantage at an integrated health system in Nevada utilizing novel clinical management and prior authorization digital health software (XpediteMD). Methods: All participants were evaluated at a single imaging facility for inconclusive or suspicious breast imaging. A total of 552 patients with Breast Imaging Reporting and Data Systems category 0, 4, or 5 radiology diagnosis were enrolled on the XpediteMD digital health platform. Seventy-two were ultimately found to have invasive or in situ breast cancer. Ten were excluded from the TTT analysis due to treatment delay caused by intercurrent illness, and 12 were excluded because they initially declined treatment. Results: For the remaining 50 patients whose cases were managed with XpediteMD, median TTT was 33 days compared with 74 days among 99 patients in the historical cohort, a significant 55% reduction in TTT (P < .0001) that exceeded the 50% TTT goal. Conclusions: By reducing TTT to 33 days, the XpediteMD platform minimized delays in initiation of breast cancer therapy that could potentially compromise patient overall survival. [ABSTRACT FROM AUTHOR] |
|
Copyright of American Journal of Accountable Care is the property of MJH Life Sciences and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| قاعدة البيانات: |
Complementary Index |
Full Text Finder